Dr. Ruiz has led drug development for a variety of indications, including chronic kidney disease, cardiovascular disease, and autoimmune disease. She has managed pharmacology, toxicology, and clinical programs for small molecules, peptides, and biologics. Her broad expertise extends to strategic guidance on product messaging, company operations, business development, and regulatory filings.
Prior to joining Renibus Therapeutics, Dr. Ruiz was VP of Drug Development and Discovery at Abcentra. She was previously Director of Research and Development and Business Development at La Jolla Pharmaceutical Company and held leadership roles in Product Development and Medical Affairs at Reata Pharmaceuticals.